Prevención de la infección por Streptococcus del grupo B en gestantes

Introducción: La infección neonatal por Streptococcus del Grupo B en mujeres gestantes es un problema creciente a nivel mundial y tiene múltiples consecuencias para el recién nacido, su prevención impacta directamente la morbi-mortalidad neonatal. Objetivo: Brindar al lector información relevante so...

Full description

Autores:
Martínez Sánchez, Lina María
Restrepo Arango, Marcos
Sánchez Díaz, Emmanuel
Marín Cárdenas, Juan Sebastián
Gallego González, Daniel
Velez Pelaez, Maria Camila
Tipo de recurso:
Article of journal
Fecha de publicación:
2017
Institución:
Universidad Autónoma de Bucaramanga - UNAB
Repositorio:
Repositorio UNAB
Idioma:
spa
OAI Identifier:
oai:repository.unab.edu.co:20.500.12749/9990
Acceso en línea:
http://hdl.handle.net/20.500.12749/9990
Palabra clave:
Streptococcus agalactiae
Antibiotic prophylaxis
Bacterial infections
Secondary prevention
Vaccines synthetic
Ciencias de la salud
Medicina
Streptococcus agalactiae
Profilaxis antibiótica
Infecciones bacterianas
Rights
License
http://creativecommons.org/licenses/by-nc-nd/2.5/co/
id UNAB2_45a5f21c6a54f324e360642dfeb1f831
oai_identifier_str oai:repository.unab.edu.co:20.500.12749/9990
network_acronym_str UNAB2
network_name_str Repositorio UNAB
repository_id_str
dc.title.spa.fl_str_mv Prevención de la infección por Streptococcus del grupo B en gestantes
dc.title.translated.eng.fl_str_mv Prevention of group B Streptococcal infection in pregnant women
title Prevención de la infección por Streptococcus del grupo B en gestantes
spellingShingle Prevención de la infección por Streptococcus del grupo B en gestantes
Streptococcus agalactiae
Antibiotic prophylaxis
Bacterial infections
Secondary prevention
Vaccines synthetic
Ciencias de la salud
Medicina
Streptococcus agalactiae
Profilaxis antibiótica
Infecciones bacterianas
title_short Prevención de la infección por Streptococcus del grupo B en gestantes
title_full Prevención de la infección por Streptococcus del grupo B en gestantes
title_fullStr Prevención de la infección por Streptococcus del grupo B en gestantes
title_full_unstemmed Prevención de la infección por Streptococcus del grupo B en gestantes
title_sort Prevención de la infección por Streptococcus del grupo B en gestantes
dc.creator.fl_str_mv Martínez Sánchez, Lina María
Restrepo Arango, Marcos
Sánchez Díaz, Emmanuel
Marín Cárdenas, Juan Sebastián
Gallego González, Daniel
Velez Pelaez, Maria Camila
dc.contributor.author.spa.fl_str_mv Martínez Sánchez, Lina María
Restrepo Arango, Marcos
Sánchez Díaz, Emmanuel
Marín Cárdenas, Juan Sebastián
Gallego González, Daniel
Velez Pelaez, Maria Camila
dc.contributor.cvlac.spa.fl_str_mv Martínez Sánchez, Lina María [0000091898]
Restrepo Arango, Marcos [0001531399]
Sánchez Díaz, Emmanuel [0001593989]
Gallego González, Daniel [0001488951]
dc.contributor.googlescholar.spa.fl_str_mv Martínez Sánchez, Lina María [C_MLAl8AAAAJ&hl=es&oi=ao]
Restrepo Arango, Marcos [rm1M7SsAAAAJ&hl=es&oi=ao]
Sánchez Díaz, Emmanuel [DDb6j8MAAAAJ&hl=es&oi=ao]
Gallego González, Daniel [6IjCYngAAAAJ&hl=es&oi=ao]
dc.contributor.orcid.spa.fl_str_mv Martínez Sánchez, Lina María [0000-0002-9555-0843]
Restrepo Arango, Marcos [0000-0002-7980-3775]
Sánchez Díaz, Emmanuel [0000-0002-1077-5796]
Gallego González, Daniel [0000-0001-5049-7877]
Vélez-Peláez, María Camila [0000-0001-5517-9640]
dc.subject.keywords.eng.fl_str_mv Streptococcus agalactiae
Antibiotic prophylaxis
Bacterial infections
Secondary prevention
Vaccines synthetic
topic Streptococcus agalactiae
Antibiotic prophylaxis
Bacterial infections
Secondary prevention
Vaccines synthetic
Ciencias de la salud
Medicina
Streptococcus agalactiae
Profilaxis antibiótica
Infecciones bacterianas
dc.subject.lemb.spa.fl_str_mv Ciencias de la salud
Medicina
dc.subject.proposal.spa.fl_str_mv Streptococcus agalactiae
Profilaxis antibiótica
Infecciones bacterianas
description Introducción: La infección neonatal por Streptococcus del Grupo B en mujeres gestantes es un problema creciente a nivel mundial y tiene múltiples consecuencias para el recién nacido, su prevención impacta directamente la morbi-mortalidad neonatal. Objetivo: Brindar al lector información relevante sobre la importancia clínica, nuevos métodos de tamizaje y formas de prevención de la infección por Streptococcus del Grupo B en gestantes, que será de utilidad para evitar complicaciones del binomio materno-fetal. Metodología: En esta revisión de la literatura, se estudiaron 53 artículos, abordando evidencia tanto en el ámbito local e internacional, utilizando las bases de datos PubMed, ScienceDirect y Google Scholar, dentro los criterios de búsqueda se tuvo en cuenta el año de publicación, incluyendo artículos que fueron publicados a partir del año 2011. Resultados: La comunidad internacional ha desarrollado guías y planes de prevención; en la actualidad, para una profilaxis y prevención adecuada se proponen diversos métodos, partiendo del tamizaje para las maternas, uso de antibióticos durante el embarazo y parto, además del desarrollo de vacunas maternas para prevenir infecciones. Conclusiones: La colonización por Streptococcus del Grupo B en gestantes y el riesgo que conlleva para el recién nacido y su madre, exige una constante actualización en técnicas de tamizaje, prevención y manejo. Numerosos avances en estos campos vienen llevándose a cabo en los últimos años y su fortalecimiento y desarrollo será clave para impactar positivamente la morbi-mortalidad materno-fetal. [Martínez-Sánchez LM, Restrepo-Arango M, Sánchez-Díaz E, Marín-Cárdenas JS, Gallego-González D, Vélez-Peláez MC. Prevención de la infección por Streptococcus del grupo B en gestantes. MedUNAB 2017; 20(2): 182-189].
publishDate 2017
dc.date.issued.none.fl_str_mv 2017-08-04
dc.date.accessioned.none.fl_str_mv 2020-10-27T14:19:33Z
dc.date.available.none.fl_str_mv 2020-10-27T14:19:33Z
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.driver.none.fl_str_mv info:eu-repo/semantics/article
dc.type.local.spa.fl_str_mv Artículo
dc.type.coar.none.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.redcol.none.fl_str_mv http://purl.org/redcol/resource_type/ART
format http://purl.org/coar/resource_type/c_6501
dc.identifier.issn.none.fl_str_mv 2382-4603
0123-7047
dc.identifier.uri.none.fl_str_mv http://hdl.handle.net/20.500.12749/9990
dc.identifier.instname.spa.fl_str_mv instname:Universidad Autónoma de Bucaramanga UNAB
dc.identifier.repourl.none.fl_str_mv repourl:https://repository.unab.edu.co
dc.identifier.doi.none.fl_str_mv 10.29375/01237047.2308
identifier_str_mv 2382-4603
0123-7047
instname:Universidad Autónoma de Bucaramanga UNAB
repourl:https://repository.unab.edu.co
10.29375/01237047.2308
url http://hdl.handle.net/20.500.12749/9990
dc.language.iso.spa.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://revistas.unab.edu.co/index.php/medunab/article/view/2308/2807
/*ref*/Cape A, Tuomala RE, Taylor C, Puopolo KM. Peripartum bacteremia in the era of group B streptococcus prophylaxis. Obstet Gynec. 2013; 121(4):812-8. Disponible en: http://goo.gl/ZQ41oy . 2. Chan GJ, Lee AC, Baqui AH, Tan J, Black RE. Risk of early-onset neonatal infection with maternal infection or colonization: a global systematic review and meta-analysis. PLoS Med. 2013; 10(8):e1001502. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/23976885 3. Ohlsson A, Shah VS. Intrapartum antibiotics for known maternal Group B streptococcal colonization. Cochrane Database Syst Rev. 2013; 3:CD007467. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/23440815 4. Faro J. More rapid testing group B streptococcus detection. MLO Med Lab Obs. 2013; 45(6):15. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/23875438 5. Baker CJ. The spectrum of perinatal group B streptococcal disease. Vaccine. 2013; 31 Suppl 4:D3-6. Disponible en: http://goo.gl/ZYboLp . 6. Kruk CR, Feuerschuette OH, da Silveira SK, Cordazo M, Trapani Júnior A. Epidemiologic profile of Streptococcus agalactiae colonization in pregnant women attending prenatal care in a city of southern of Brazil. Braz J Infect Dis. 2013; 17(6):722-3. Disponible en: http://goo.gl/zvnqtN . 7. Page-Ramsey SM, Johnstone SK, Kim D, Ramsey PS. Prevalence of group B Streptococcus colonization in subsequent pregnancies of group B Streptococcus-colonized versus noncolonized women. Am J Perinatol. 2012; 30(5):383-8. Disponible en: http://goo.gl/9XEpWm . 8. Berardi A, Rossi C, Creti R, China M, Gherardi G, Venturelli C, et al. Group B streptococcal colonization in 160 mother-baby pairs: a prospective cohort study. J Pediatr. 2013; 163(4):1099-104. Disponible en: http://goo.gl/wJ1hGA . 9. Oh W. Early onset neonatal group B streptococcal sepsis. Am J Perinatol. 2013; 30(2):143-7. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/23322392 . 10. Brzychczy-Wloch M, Wojkowska-Mach J, Helwich E, Heczko PB. Incidence of maternal SGB colonization and neonatal SGB disease among very low birth weight Polish neonates. Med Sci Monit. 2014; 19:34-9. Disponible en: http://goo.gl/IjA2rb . 11. Berardi A, Rossi C, Lugli L, Creti R, Bacchi ML, Lanari M, et al. SGB Prevention Working Group, Emilia-Romagna. Group B streptococcus late-onset disease: 2003-2010. Pediatrics. 2013; 131(2):e361-8. Disponible en: http://goo.gl/b1o0l6. 12. Park JS, Cho DH, Yang JH, Kim MY, Shin SM, Kim EC, et al. Usefulness of a rapid real-time PCR assay in prenatal screening for group B streptococcus colonization. Ann Lab Med. 2013; 33(1):39-44. Disponible en: http://goo.gl/4CQmKm . 13. Yancey MK, Schuchat A, Brown LK, Ventura VL, Markenson GR. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet Gynecol. 1996; 88:811-5. 14. Verani J, McGee L, Schrag S. Prevention of perinatal group B streptococcal disease, 2010. MMWR Recomm Rep. 2010; 59:1-36. 15. Sheehy A, Davis D, Homer CS. Assisting women to make informed choices about screening for Group B Streptococcus in pregnancy: a critical review of the evidence. Women Birth. 2013; 26(2):152-7. Disponible en: http://goo.gl/DqzOZc 16. Guerrero C, Martinez J, Menasalvas A, Blazquez R, Rodriguez T, Segovia M. Use of direct latex agglutination testing of selective broth in the detection of group B streptococcal carriage in pregnant women. Eur J Clin Microbiol Infect Dis. 2004; 23:61-2. 17. Bourgeois-Nicolaos N, Cordier AG, Guillet-Caruba C, Casanova F, Benachi A, Doucet-Populaire F. Evaluation of the Cepheid Xpert SGB assay for rapid detection of group B Streptococci in amniotic fluids from pregnant women with premature rupture of membranes. J Clin Microbiol. 2013; 51(4):1305-6. Disponible en: http://goo.gl/VAE9Qi 18. Faro JP, Bishop K, Riddle G, Ramirez MM, Katz AR, Turrentine MA, et al. Accuracy of an accelerated, culture-based assay for detection of group B streptococcus. Infect Dis Obstet Gynecol. 2013; 2013:367935. Disponible en : http://goo.gl/G0TPd7 . 19. Poncelet-Jasserand E, Forges F, Varlet MN, Chauleur C, Seffert P, Siani C, et al. Reduction of the use of antimicrobial drugs following the rapid detection of Streptococcus agalactiae in the vagina at delivery by real-time PCR assay. BJOG. 2013; 120(9):1098-108. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/23656626 20. Berg BR, Houseman JL, Garrasi MA, Young CL, Newton DW. Culture-based method with performance comparable to that of PCR-based methods for detection of group B Streptococcus in screening samples from pregnant women. J Clin Microbiol. 2013; 51(4):1253-5. Disponible en: http://goo.gl/NimCEG . 21. Burns G, Plumb J. GBS public awareness, advocacy, and prevention--what's working, what's not and why we need a maternal GBS vaccine. Vaccine. 2013; 31, Suppl 4:D58-65. Disponible en: http://goo.gl/YR6MKq 22. Horváth B, Grasselly M, Bödecs T, Boncz I, Bódis J. Screening pregnant women for group B streptococcus infection between 30 and 32weeks of pregnancy in a population at high risk for premature birth. Int J Gynaecol Obstetl. 2013; 122(1):9-12. Disponible en: http://goo.gl/IZW7I5 . 23. Kimura K, Matsubara K, Yamamoto G, Shibayama K, Arakawa Y. Active screening of group B streptococci with reduced penicillin susceptibility and altered serotype distribution isolated from pregnant women in Kobe, Japan. Jpn J Infect Dis. 2013; 66(2):158-60. Disponible en: http://goo.gl/OPsblL 24. Capanna F, Emonet SP, Cherkaoui A, Irion O, Schrenzel J, Martinez de Tejada B. Antibiotic resistance patterns among group B Streptococcus isolates: implications for antibiotic prophylaxis for early-onset neonatal sepsis. Swiss Med Wkly. 2013; 25:143. Disponible en: http://goo.gl/QZR8kT . 25. Duque CM, Gómez B, Sánchez DM , Uribe OL. Perfil de sensibilidad de S. agalactiae obtenido a partir de muestras de introito vaginal y región perineal de mujeres gestantes de Medellín (Colombia). NOVA. Publicación Científica EN CIENCIAS BIOMÉDICAS. 2011; 9(15): Disponible en: http://www.unicolmayor.edu.co/invest_nova/NOVA/NOVA15_ARTORIG2_PERFIL.pdf. 26. Crespo-Ortiz Mdel P, Castañeda-Ramirez CR, Recalde-Bolaños M, Vélez-Londoño JD. Emerging trends in invasive and noninvasive isolates of Streptococcus agalactiae in a Latin American hospital: a 17-year study. BMC Infect Dis. 2014; 14:428. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/25086463 27. Megged O, Assous M, Weinberg G, Schlesinger Y. Inducible clindamycin resistance in β-hemolytic streptococci and Streptococcus pneumoniae. Isr Med Assoc J. 2013; 15(1):27-30. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/23484235 28. Paccione KA, Wiesenfeld HC. Guideline adherence for intrapartum group B streptococci prophylaxis in penicillin-allergic patients. Infect Dis Obstet Gynecol. 2013; 2013:917304. Disponible en: http://goo.gl/v575Tv 29. Simons FE, Schatz M. Anaphylaxis during pregnancy. J Allergy Clin Immunol. 2013; 130(3):597-606. Disponible en: http://goo.gl/ppJ1Uc . 30. Faro J, Katz A, Ramirez M, Turrentine M, Bishop K, Riddle G, et al. Rapid test for growth and determination of antibiotic sensitivity of Group B Streptococcus (SGB) in antepartum women. Am J Obstet Gynecol. 2012; 206(1): S268. Disponible en: http://goo.gl/YjP1qU . 31. Fairlie T, Zell ER, Schrag S. Effectiveness of intrapartum antibiotic prophylaxis for prevention of early-onset group B streptococcal disease. Obstet Gynecol. 2013; 121(3):570-7. Disponible en: http://goo.gl/7BPqcz . 32. Turrentine MA, Greisinger AJ, Brown KS, Wehmanen OA, Mouzoon ME. Duration of intrapartum antibiotics for group B streptococcus on the diagnosis of clinical neonatal sepsis. Infect Dis Obstet Gynecol. 2013; 2013:525878. Disponible en: http://goo.gl/FdD7f8 33. Schrag SJ, Verani JR. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine. Vaccine. 2013; 28:31. Disponible en: http://goo.gl/2JyCYi . 34. Centers for Disease Control and Prevention. Prevention of Perinatal Group B Streptococcal Disease Revised Guidelines from CDC, 2010. Disponible en : http://www.cdc.gov/groupbstrep/guidelines 35. Bromiker R, Ernest N, Meir MB, Kaplan M, Hammerman C, Schimmel MS, et al . Correlation of bacterial type and antibiotic sensitivity with maternal antibiotic exposure in early-onset neonatal sepsis. Neonatology. 2013;103(1):48-53. Disponible en : http://goo.gl/Wab4ra . 36. Natale F, Brunelli R, Bizzarri B, Castronovo A, De Curtis M. Cervical insufficiency: a new issue for guidelines on prevention of perinatal group B streptococcal disease? Pediatrics. 2013; 131(2):e612-5. Disponible en: http://goo.gl/7NqJ5J . 37. Swamy GK, Garcia-Putnam R. Vaccine-preventable diseases in pregnancy. Am J Perinatol. 2013; 30(2):89-97. Disponible en: http://goo.gl/KRG4ed . 38. Esposito S, Bosis S, Morlacchi L, Baggi E, Sabatini C, Principi N. Can infants be protected by means of maternal vaccination? Clin Microbiol Infect. 2012; 18 Suppl 5:85-92. Disponible en: http://goo.gl/TSKpRR . 39. Lindsey B, Kampmann B, Jones C. Maternal immunization as a strategy to decrease susceptibility to infection in newborn infants. Curr Opin Infect Dis. 2013; 26(3):248-53. Disponible en: http://goo.gl/zQfS32 . 40. Melin P, Efstratiou A. Group B streptococcal epidemiology and vaccine needs in developed countries. Vaccine. 2013; 28;31 Suppl 4:D31-42. Disponible en: http://goo.gl/hGvBTZ 41. Kasper DL, Paoletti LC, Wessels MR, Guttormsen HK, Carey VJ, Jennings HJ, Baker CJ. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J Clin Invest. 1996; 98(10). Disponible en : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC507681/ 42. Madhi SA, Dangor Z, Heath PT, Schrag S, Izu A, Sobanjo-Ter Meulen A, et al . Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants. Vaccine. 2013; 28;31 Suppl 4:D52-7. Disponible en: http://goo.gl/UWMwP9 . 43. Munoz FM, Ferrieri P. Group B Streptococcus vaccination in pregnancy: moving toward a global maternal immunization program. Vaccine. 2013; 28;31 Suppl 4:D46-5. Disponible en: http://goo.gl/a9u4sc . 44. Souza VC, Kegele FC, Souza SR, Neves FP, de Paula GR, Barros RR. Antimicrobial susceptibility and genetic diversity of Streptococcus agalactiae recovered from newborns and pregnant women in Brazil. Scand J Infect Dis. 2013; 45(10):780-5. Disponible en: http://goo.gl/IwMHaR 45. Bellais S, Six A, Fouet A, Longo M, Dmytruk N, Glaser P, Trieu-Cuot P, Poyart C. Capsular switching in group B Streptococcus CC17 hypervirulent clone: a future challenge for polysaccharide vaccine development. J Infect Dis. 2012; 206(11):1745-52. Disponible en: http://goo.gl/YPFksR . 46. Brzychczy-Wloch M, Gorska S, Brzozowska E, Gamian A, Heczko PB, Bulanda M. Identification of high immunoreactive proteins from Streptococcus agalactiae isolates recognized by human serum antibodies. FEMS Microbiol Lett. 2013; 349(1):61-70. Disponible en: http://goo.gl/E75eda . 47. Chen VL, Avci FY, Kasper DL. A maternal vaccine against group B Streptococcus: past, present, and future. Vaccine. 2013; 31 Suppl 4:D13-9. Disponible en: http://goo.gl/ifcr2B . 48. Edwards MS, Gonik B. Preventing the broad spectrum of perinatal morbidity and mortality through group B streptococcal vaccination. Vaccine. 2013; 31Suppl 4:D66-71. Disponible en: http://goo.gl/CCZm1q 49. Edwards MS, Lane HJ, Hillier SL, Rench MA, Baker CJ. Persistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccines. Vaccine. 2013; 30(28):4123-6. Disponible en: http://goo.gl/b5q2ff 50. Le Doare K, Heath PT. An overview of global GBS epidemiology. Vaccine. 2013; 31 Suppl 4:D7-12. Disponible en: http://goo.gl/tnjV00 . 51. Koumans EH, Rosen J, van Dyke MK, Zell E, Phares CR, Taylor A,et al . Prevention of mother-to-child transmission of infections during pregnancy: implementation of recommended interventions, United States, 2003-2004. Am J Obstet Gynecol. 2012; 206(2):158.e1-158.e11. Disponible en: http://goo.gl/rdsoIo . 52. Johri AK, Lata H, Yadav P, Dua M, Yang Y, Xu X, et al. Epidemiology of Group B Streptococcus in developing countries. Vaccine. 2013; 31 Suppl 4:D43-5. Disponible en: http://goo.gl/ucTuO5 53. Dagnew AF, Cunnington MC, Dube Q, Edwards MS, French N, Heyderman RS,et al. Variation in reported neonatal group B streptococcal disease incidence in developing countries. Clin Infect Dis.2012; 55(1):91-102. Disponible en: http://goo.gl/tPJvkI .
dc.relation.uri.none.fl_str_mv https://revistas.unab.edu.co/index.php/medunab/article/view/2308
dc.relation.references.spa.fl_str_mv Chan GJ, Lee AC, Baqui AH, Tan J, Black RE. Risk of early-onset neonatal infection with maternal infection or colonization: a global systematic review and meta-analysis. PLoS Med. 2013; 10(8):e1001502. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/23976885
CapeA,TuomalaRE,TaylorC,PuopoloKM. PeripartumbacteremiaintheeraofgroupB streptococcusprophylaxis.ObstetGynec.2013; 121(4):812-8. Disponible en: http://goo.gl/ZQ41oy
Ohlsson A, Shah VS. Intrapartum antibiotics for known maternal Group B streptococcal colonization. Cochrane Database Syst Rev. 2013; 3:CD007467. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/23440815
FaroJ.MorerapidtestinggroupBstreptococcus detection.MLOMedLabObs.2013;45(6):15. Disponibleen:http://www.ncbi.nlm.nih.gov/pubmed/ 23875438
BakerCJ.ThespectrumofperinatalgroupB streptococcal disease. Vaccine. 2013; 31 Suppl 4:D3-6. Disponible en: http://goo.gl/ZYboLp
Page-Ramsey SM, Johnstone SK, Kim D, Ramsey PS. Prevalence of group B Streptococcus colonization in subsequentpregnanciesofgroupBStreptococcus-colonized versus noncolonized women. Am J Perinatol. 2012; 30(5):383-8. Disponible en: http://goo.gl/9XEpWm
Berardi A, Rossi C, Creti R, China M, Gherardi G, Venturelli C, et al. Group B streptococcal colonization in 160 mother-baby pairs: a prospective cohort study. J Pediatr.2013;163(4):1099-104.Disponibleen: http://goo.gl/wJ1hGA
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.uri.none.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.rights.creativecommons.*.fl_str_mv Atribución-NoComercial-SinDerivadas 2.5 Colombia
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/co/
Atribución-NoComercial-SinDerivadas 2.5 Colombia
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidad Autónoma de Bucaramanga UNAB
dc.publisher.faculty.spa.fl_str_mv Facultad Ciencias de la Salud
dc.publisher.program.spa.fl_str_mv Pregrado Medicina
publisher.none.fl_str_mv Universidad Autónoma de Bucaramanga UNAB
dc.source.none.fl_str_mv MedUNAB; Vol. 20 Núm. 2 (2017): Agosto - Noviembre de 2017: Prevención de Caídas, Educación Médica, Leishmaniasis Cutánea; 182-189
institution Universidad Autónoma de Bucaramanga - UNAB
bitstream.url.fl_str_mv https://repository.unab.edu.co/bitstream/20.500.12749/9990/1/2017_Prevenci%c3%b3n_de_la_infecci%c3%b3n.pdf
https://repository.unab.edu.co/bitstream/20.500.12749/9990/2/2017_Prevenci%c3%b3n_de_la_infecci%c3%b3n.pdf.jpg
bitstream.checksum.fl_str_mv 2404166bfd894f86bb4fe6379a211f50
cea0f2683ab0dc6f6da976c17858fc23
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositorio Institucional | Universidad Autónoma de Bucaramanga - UNAB
repository.mail.fl_str_mv repositorio@unab.edu.co
_version_ 1814277353462824960
spelling Martínez Sánchez, Lina María82474f83-2774-4d7e-8337-6564a185d514Restrepo Arango, Marcos30a760b8-cc1b-493b-baab-6a938f86a519Sánchez Díaz, Emmanuel1a6e0d1d-21ef-474c-8294-8528da7e838aMarín Cárdenas, Juan Sebastián5bae4452-f461-4984-954a-102088429193Gallego González, Daniel66442cee-805c-4a03-952f-fad27b709776Velez Pelaez, Maria Camila7d0cc71f-5009-48c5-9620-4aecb219c74cMartínez Sánchez, Lina María [0000091898]Restrepo Arango, Marcos [0001531399]Sánchez Díaz, Emmanuel [0001593989]Gallego González, Daniel [0001488951]Martínez Sánchez, Lina María [C_MLAl8AAAAJ&hl=es&oi=ao]Restrepo Arango, Marcos [rm1M7SsAAAAJ&hl=es&oi=ao]Sánchez Díaz, Emmanuel [DDb6j8MAAAAJ&hl=es&oi=ao]Gallego González, Daniel [6IjCYngAAAAJ&hl=es&oi=ao]Martínez Sánchez, Lina María [0000-0002-9555-0843]Restrepo Arango, Marcos [0000-0002-7980-3775]Sánchez Díaz, Emmanuel [0000-0002-1077-5796]Gallego González, Daniel [0000-0001-5049-7877]Vélez-Peláez, María Camila [0000-0001-5517-9640]2020-10-27T14:19:33Z2020-10-27T14:19:33Z2017-08-042382-46030123-7047http://hdl.handle.net/20.500.12749/9990instname:Universidad Autónoma de Bucaramanga UNABrepourl:https://repository.unab.edu.co10.29375/01237047.2308Introducción: La infección neonatal por Streptococcus del Grupo B en mujeres gestantes es un problema creciente a nivel mundial y tiene múltiples consecuencias para el recién nacido, su prevención impacta directamente la morbi-mortalidad neonatal. Objetivo: Brindar al lector información relevante sobre la importancia clínica, nuevos métodos de tamizaje y formas de prevención de la infección por Streptococcus del Grupo B en gestantes, que será de utilidad para evitar complicaciones del binomio materno-fetal. Metodología: En esta revisión de la literatura, se estudiaron 53 artículos, abordando evidencia tanto en el ámbito local e internacional, utilizando las bases de datos PubMed, ScienceDirect y Google Scholar, dentro los criterios de búsqueda se tuvo en cuenta el año de publicación, incluyendo artículos que fueron publicados a partir del año 2011. Resultados: La comunidad internacional ha desarrollado guías y planes de prevención; en la actualidad, para una profilaxis y prevención adecuada se proponen diversos métodos, partiendo del tamizaje para las maternas, uso de antibióticos durante el embarazo y parto, además del desarrollo de vacunas maternas para prevenir infecciones. Conclusiones: La colonización por Streptococcus del Grupo B en gestantes y el riesgo que conlleva para el recién nacido y su madre, exige una constante actualización en técnicas de tamizaje, prevención y manejo. Numerosos avances en estos campos vienen llevándose a cabo en los últimos años y su fortalecimiento y desarrollo será clave para impactar positivamente la morbi-mortalidad materno-fetal. [Martínez-Sánchez LM, Restrepo-Arango M, Sánchez-Díaz E, Marín-Cárdenas JS, Gallego-González D, Vélez-Peláez MC. Prevención de la infección por Streptococcus del grupo B en gestantes. MedUNAB 2017; 20(2): 182-189].Introduction: The neonatal infection by Group B Streptococcus in pregnant women is a growing problem worldwide and has multiple consequences for the newborn, so its prevention directly impacts neonatal morbimortality. Objective: To provide the reader with relevant information about the clinical importance, new screening methods and ways to prevent Group B Streptococcus infection in pregnant women which will be useful to avoid complications in the pairing of maternal-fetal. Methodology: In this review of literature, 53 articles were studied addressing local and international evidence by using PubMed, ScienceDirect and Google Scholar databases; within the search criteria the year of publication was taken into account to do so, thus articles published from 2011 were included. Results: The international community has developed guidelines and prevention plans for this infection. Currently, for an adequate prophylaxis and prevention, various methods are proposed such as the screening for expectant mothers, the use of antibiotics during pregnancy and childbirth, and the development of maternal immunization to prevent infections as well. Conclusions: The colonization by Group B Streptococcus in pregnant women and the risk that this entails to the newborn and his/her mother requires constant updating in techniques for screening, prevention and management of it. Numerous advances in these fields of study have been carried out in recent years, and this strengthening and its development will be the key to impact, in a positive way, the maternal-fetal morbimortality. [Martínez-Sánchez LM, Restrepo-Arango M, Sánchez-Díaz E, Marín-Cárdenas JS, Gallego-González D, Vélez-Peláez MC. Prevention of Group B Streptococcal Infection in Pregnant Women. MedUNAB 2017; 20(2): 182-189].application/pdfspaUniversidad Autónoma de Bucaramanga UNABFacultad Ciencias de la SaludPregrado Medicinahttps://revistas.unab.edu.co/index.php/medunab/article/view/2308/2807/*ref*/Cape A, Tuomala RE, Taylor C, Puopolo KM. Peripartum bacteremia in the era of group B streptococcus prophylaxis. Obstet Gynec. 2013; 121(4):812-8. Disponible en: http://goo.gl/ZQ41oy . 2. Chan GJ, Lee AC, Baqui AH, Tan J, Black RE. Risk of early-onset neonatal infection with maternal infection or colonization: a global systematic review and meta-analysis. PLoS Med. 2013; 10(8):e1001502. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/23976885 3. Ohlsson A, Shah VS. Intrapartum antibiotics for known maternal Group B streptococcal colonization. Cochrane Database Syst Rev. 2013; 3:CD007467. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/23440815 4. Faro J. More rapid testing group B streptococcus detection. MLO Med Lab Obs. 2013; 45(6):15. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/23875438 5. Baker CJ. The spectrum of perinatal group B streptococcal disease. Vaccine. 2013; 31 Suppl 4:D3-6. Disponible en: http://goo.gl/ZYboLp . 6. Kruk CR, Feuerschuette OH, da Silveira SK, Cordazo M, Trapani Júnior A. Epidemiologic profile of Streptococcus agalactiae colonization in pregnant women attending prenatal care in a city of southern of Brazil. Braz J Infect Dis. 2013; 17(6):722-3. Disponible en: http://goo.gl/zvnqtN . 7. Page-Ramsey SM, Johnstone SK, Kim D, Ramsey PS. Prevalence of group B Streptococcus colonization in subsequent pregnancies of group B Streptococcus-colonized versus noncolonized women. Am J Perinatol. 2012; 30(5):383-8. Disponible en: http://goo.gl/9XEpWm . 8. Berardi A, Rossi C, Creti R, China M, Gherardi G, Venturelli C, et al. Group B streptococcal colonization in 160 mother-baby pairs: a prospective cohort study. J Pediatr. 2013; 163(4):1099-104. Disponible en: http://goo.gl/wJ1hGA . 9. Oh W. Early onset neonatal group B streptococcal sepsis. Am J Perinatol. 2013; 30(2):143-7. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/23322392 . 10. Brzychczy-Wloch M, Wojkowska-Mach J, Helwich E, Heczko PB. Incidence of maternal SGB colonization and neonatal SGB disease among very low birth weight Polish neonates. Med Sci Monit. 2014; 19:34-9. Disponible en: http://goo.gl/IjA2rb . 11. Berardi A, Rossi C, Lugli L, Creti R, Bacchi ML, Lanari M, et al. SGB Prevention Working Group, Emilia-Romagna. Group B streptococcus late-onset disease: 2003-2010. Pediatrics. 2013; 131(2):e361-8. Disponible en: http://goo.gl/b1o0l6. 12. Park JS, Cho DH, Yang JH, Kim MY, Shin SM, Kim EC, et al. Usefulness of a rapid real-time PCR assay in prenatal screening for group B streptococcus colonization. Ann Lab Med. 2013; 33(1):39-44. Disponible en: http://goo.gl/4CQmKm . 13. Yancey MK, Schuchat A, Brown LK, Ventura VL, Markenson GR. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet Gynecol. 1996; 88:811-5. 14. Verani J, McGee L, Schrag S. Prevention of perinatal group B streptococcal disease, 2010. MMWR Recomm Rep. 2010; 59:1-36. 15. Sheehy A, Davis D, Homer CS. Assisting women to make informed choices about screening for Group B Streptococcus in pregnancy: a critical review of the evidence. Women Birth. 2013; 26(2):152-7. Disponible en: http://goo.gl/DqzOZc 16. Guerrero C, Martinez J, Menasalvas A, Blazquez R, Rodriguez T, Segovia M. Use of direct latex agglutination testing of selective broth in the detection of group B streptococcal carriage in pregnant women. Eur J Clin Microbiol Infect Dis. 2004; 23:61-2. 17. Bourgeois-Nicolaos N, Cordier AG, Guillet-Caruba C, Casanova F, Benachi A, Doucet-Populaire F. Evaluation of the Cepheid Xpert SGB assay for rapid detection of group B Streptococci in amniotic fluids from pregnant women with premature rupture of membranes. J Clin Microbiol. 2013; 51(4):1305-6. Disponible en: http://goo.gl/VAE9Qi 18. Faro JP, Bishop K, Riddle G, Ramirez MM, Katz AR, Turrentine MA, et al. Accuracy of an accelerated, culture-based assay for detection of group B streptococcus. Infect Dis Obstet Gynecol. 2013; 2013:367935. Disponible en : http://goo.gl/G0TPd7 . 19. Poncelet-Jasserand E, Forges F, Varlet MN, Chauleur C, Seffert P, Siani C, et al. Reduction of the use of antimicrobial drugs following the rapid detection of Streptococcus agalactiae in the vagina at delivery by real-time PCR assay. BJOG. 2013; 120(9):1098-108. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/23656626 20. Berg BR, Houseman JL, Garrasi MA, Young CL, Newton DW. Culture-based method with performance comparable to that of PCR-based methods for detection of group B Streptococcus in screening samples from pregnant women. J Clin Microbiol. 2013; 51(4):1253-5. Disponible en: http://goo.gl/NimCEG . 21. Burns G, Plumb J. GBS public awareness, advocacy, and prevention--what's working, what's not and why we need a maternal GBS vaccine. Vaccine. 2013; 31, Suppl 4:D58-65. Disponible en: http://goo.gl/YR6MKq 22. Horváth B, Grasselly M, Bödecs T, Boncz I, Bódis J. Screening pregnant women for group B streptococcus infection between 30 and 32weeks of pregnancy in a population at high risk for premature birth. Int J Gynaecol Obstetl. 2013; 122(1):9-12. Disponible en: http://goo.gl/IZW7I5 . 23. Kimura K, Matsubara K, Yamamoto G, Shibayama K, Arakawa Y. Active screening of group B streptococci with reduced penicillin susceptibility and altered serotype distribution isolated from pregnant women in Kobe, Japan. Jpn J Infect Dis. 2013; 66(2):158-60. Disponible en: http://goo.gl/OPsblL 24. Capanna F, Emonet SP, Cherkaoui A, Irion O, Schrenzel J, Martinez de Tejada B. Antibiotic resistance patterns among group B Streptococcus isolates: implications for antibiotic prophylaxis for early-onset neonatal sepsis. Swiss Med Wkly. 2013; 25:143. Disponible en: http://goo.gl/QZR8kT . 25. Duque CM, Gómez B, Sánchez DM , Uribe OL. Perfil de sensibilidad de S. agalactiae obtenido a partir de muestras de introito vaginal y región perineal de mujeres gestantes de Medellín (Colombia). NOVA. Publicación Científica EN CIENCIAS BIOMÉDICAS. 2011; 9(15): Disponible en: http://www.unicolmayor.edu.co/invest_nova/NOVA/NOVA15_ARTORIG2_PERFIL.pdf. 26. Crespo-Ortiz Mdel P, Castañeda-Ramirez CR, Recalde-Bolaños M, Vélez-Londoño JD. Emerging trends in invasive and noninvasive isolates of Streptococcus agalactiae in a Latin American hospital: a 17-year study. BMC Infect Dis. 2014; 14:428. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/25086463 27. Megged O, Assous M, Weinberg G, Schlesinger Y. Inducible clindamycin resistance in β-hemolytic streptococci and Streptococcus pneumoniae. Isr Med Assoc J. 2013; 15(1):27-30. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/23484235 28. Paccione KA, Wiesenfeld HC. Guideline adherence for intrapartum group B streptococci prophylaxis in penicillin-allergic patients. Infect Dis Obstet Gynecol. 2013; 2013:917304. Disponible en: http://goo.gl/v575Tv 29. Simons FE, Schatz M. Anaphylaxis during pregnancy. J Allergy Clin Immunol. 2013; 130(3):597-606. Disponible en: http://goo.gl/ppJ1Uc . 30. Faro J, Katz A, Ramirez M, Turrentine M, Bishop K, Riddle G, et al. Rapid test for growth and determination of antibiotic sensitivity of Group B Streptococcus (SGB) in antepartum women. Am J Obstet Gynecol. 2012; 206(1): S268. Disponible en: http://goo.gl/YjP1qU . 31. Fairlie T, Zell ER, Schrag S. Effectiveness of intrapartum antibiotic prophylaxis for prevention of early-onset group B streptococcal disease. Obstet Gynecol. 2013; 121(3):570-7. Disponible en: http://goo.gl/7BPqcz . 32. Turrentine MA, Greisinger AJ, Brown KS, Wehmanen OA, Mouzoon ME. Duration of intrapartum antibiotics for group B streptococcus on the diagnosis of clinical neonatal sepsis. Infect Dis Obstet Gynecol. 2013; 2013:525878. Disponible en: http://goo.gl/FdD7f8 33. Schrag SJ, Verani JR. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine. Vaccine. 2013; 28:31. Disponible en: http://goo.gl/2JyCYi . 34. Centers for Disease Control and Prevention. Prevention of Perinatal Group B Streptococcal Disease Revised Guidelines from CDC, 2010. Disponible en : http://www.cdc.gov/groupbstrep/guidelines 35. Bromiker R, Ernest N, Meir MB, Kaplan M, Hammerman C, Schimmel MS, et al . Correlation of bacterial type and antibiotic sensitivity with maternal antibiotic exposure in early-onset neonatal sepsis. Neonatology. 2013;103(1):48-53. Disponible en : http://goo.gl/Wab4ra . 36. Natale F, Brunelli R, Bizzarri B, Castronovo A, De Curtis M. Cervical insufficiency: a new issue for guidelines on prevention of perinatal group B streptococcal disease? Pediatrics. 2013; 131(2):e612-5. Disponible en: http://goo.gl/7NqJ5J . 37. Swamy GK, Garcia-Putnam R. Vaccine-preventable diseases in pregnancy. Am J Perinatol. 2013; 30(2):89-97. Disponible en: http://goo.gl/KRG4ed . 38. Esposito S, Bosis S, Morlacchi L, Baggi E, Sabatini C, Principi N. Can infants be protected by means of maternal vaccination? Clin Microbiol Infect. 2012; 18 Suppl 5:85-92. Disponible en: http://goo.gl/TSKpRR . 39. Lindsey B, Kampmann B, Jones C. Maternal immunization as a strategy to decrease susceptibility to infection in newborn infants. Curr Opin Infect Dis. 2013; 26(3):248-53. Disponible en: http://goo.gl/zQfS32 . 40. Melin P, Efstratiou A. Group B streptococcal epidemiology and vaccine needs in developed countries. Vaccine. 2013; 28;31 Suppl 4:D31-42. Disponible en: http://goo.gl/hGvBTZ 41. Kasper DL, Paoletti LC, Wessels MR, Guttormsen HK, Carey VJ, Jennings HJ, Baker CJ. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J Clin Invest. 1996; 98(10). Disponible en : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC507681/ 42. Madhi SA, Dangor Z, Heath PT, Schrag S, Izu A, Sobanjo-Ter Meulen A, et al . Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants. Vaccine. 2013; 28;31 Suppl 4:D52-7. Disponible en: http://goo.gl/UWMwP9 . 43. Munoz FM, Ferrieri P. Group B Streptococcus vaccination in pregnancy: moving toward a global maternal immunization program. Vaccine. 2013; 28;31 Suppl 4:D46-5. Disponible en: http://goo.gl/a9u4sc . 44. Souza VC, Kegele FC, Souza SR, Neves FP, de Paula GR, Barros RR. Antimicrobial susceptibility and genetic diversity of Streptococcus agalactiae recovered from newborns and pregnant women in Brazil. Scand J Infect Dis. 2013; 45(10):780-5. Disponible en: http://goo.gl/IwMHaR 45. Bellais S, Six A, Fouet A, Longo M, Dmytruk N, Glaser P, Trieu-Cuot P, Poyart C. Capsular switching in group B Streptococcus CC17 hypervirulent clone: a future challenge for polysaccharide vaccine development. J Infect Dis. 2012; 206(11):1745-52. Disponible en: http://goo.gl/YPFksR . 46. Brzychczy-Wloch M, Gorska S, Brzozowska E, Gamian A, Heczko PB, Bulanda M. Identification of high immunoreactive proteins from Streptococcus agalactiae isolates recognized by human serum antibodies. FEMS Microbiol Lett. 2013; 349(1):61-70. Disponible en: http://goo.gl/E75eda . 47. Chen VL, Avci FY, Kasper DL. A maternal vaccine against group B Streptococcus: past, present, and future. Vaccine. 2013; 31 Suppl 4:D13-9. Disponible en: http://goo.gl/ifcr2B . 48. Edwards MS, Gonik B. Preventing the broad spectrum of perinatal morbidity and mortality through group B streptococcal vaccination. Vaccine. 2013; 31Suppl 4:D66-71. Disponible en: http://goo.gl/CCZm1q 49. Edwards MS, Lane HJ, Hillier SL, Rench MA, Baker CJ. Persistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccines. Vaccine. 2013; 30(28):4123-6. Disponible en: http://goo.gl/b5q2ff 50. Le Doare K, Heath PT. An overview of global GBS epidemiology. Vaccine. 2013; 31 Suppl 4:D7-12. Disponible en: http://goo.gl/tnjV00 . 51. Koumans EH, Rosen J, van Dyke MK, Zell E, Phares CR, Taylor A,et al . Prevention of mother-to-child transmission of infections during pregnancy: implementation of recommended interventions, United States, 2003-2004. Am J Obstet Gynecol. 2012; 206(2):158.e1-158.e11. Disponible en: http://goo.gl/rdsoIo . 52. Johri AK, Lata H, Yadav P, Dua M, Yang Y, Xu X, et al. Epidemiology of Group B Streptococcus in developing countries. Vaccine. 2013; 31 Suppl 4:D43-5. Disponible en: http://goo.gl/ucTuO5 53. Dagnew AF, Cunnington MC, Dube Q, Edwards MS, French N, Heyderman RS,et al. Variation in reported neonatal group B streptococcal disease incidence in developing countries. Clin Infect Dis.2012; 55(1):91-102. Disponible en: http://goo.gl/tPJvkI .https://revistas.unab.edu.co/index.php/medunab/article/view/2308Chan GJ, Lee AC, Baqui AH, Tan J, Black RE. Risk of early-onset neonatal infection with maternal infection or colonization: a global systematic review and meta-analysis. PLoS Med. 2013; 10(8):e1001502. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/23976885CapeA,TuomalaRE,TaylorC,PuopoloKM. PeripartumbacteremiaintheeraofgroupB streptococcusprophylaxis.ObstetGynec.2013; 121(4):812-8. Disponible en: http://goo.gl/ZQ41oyOhlsson A, Shah VS. Intrapartum antibiotics for known maternal Group B streptococcal colonization. Cochrane Database Syst Rev. 2013; 3:CD007467. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/23440815FaroJ.MorerapidtestinggroupBstreptococcus detection.MLOMedLabObs.2013;45(6):15. Disponibleen:http://www.ncbi.nlm.nih.gov/pubmed/ 23875438BakerCJ.ThespectrumofperinatalgroupB streptococcal disease. Vaccine. 2013; 31 Suppl 4:D3-6. Disponible en: http://goo.gl/ZYboLpPage-Ramsey SM, Johnstone SK, Kim D, Ramsey PS. Prevalence of group B Streptococcus colonization in subsequentpregnanciesofgroupBStreptococcus-colonized versus noncolonized women. Am J Perinatol. 2012; 30(5):383-8. Disponible en: http://goo.gl/9XEpWmBerardi A, Rossi C, Creti R, China M, Gherardi G, Venturelli C, et al. Group B streptococcal colonization in 160 mother-baby pairs: a prospective cohort study. J Pediatr.2013;163(4):1099-104.Disponibleen: http://goo.gl/wJ1hGAhttp://creativecommons.org/licenses/by-nc-nd/2.5/co/Atribución-NoComercial-SinDerivadas 2.5 Colombiahttp://purl.org/coar/access_right/c_abf2MedUNAB; Vol. 20 Núm. 2 (2017): Agosto - Noviembre de 2017: Prevención de Caídas, Educación Médica, Leishmaniasis Cutánea; 182-189Prevención de la infección por Streptococcus del grupo B en gestantesPrevention of group B Streptococcal infection in pregnant womeninfo:eu-repo/semantics/articleArtículohttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1http://purl.org/redcol/resource_type/ARThttp://purl.org/coar/version/c_970fb48d4fbd8a85Streptococcus agalactiaeAntibiotic prophylaxisBacterial infectionsSecondary preventionVaccines syntheticCiencias de la saludMedicinaStreptococcus agalactiaeProfilaxis antibióticaInfecciones bacterianasORIGINAL2017_Prevención_de_la_infección.pdf2017_Prevención_de_la_infección.pdfArticuloapplication/pdf937937https://repository.unab.edu.co/bitstream/20.500.12749/9990/1/2017_Prevenci%c3%b3n_de_la_infecci%c3%b3n.pdf2404166bfd894f86bb4fe6379a211f50MD51open accessTHUMBNAIL2017_Prevención_de_la_infección.pdf.jpg2017_Prevención_de_la_infección.pdf.jpgIM Thumbnailimage/jpeg9225https://repository.unab.edu.co/bitstream/20.500.12749/9990/2/2017_Prevenci%c3%b3n_de_la_infecci%c3%b3n.pdf.jpgcea0f2683ab0dc6f6da976c17858fc23MD52open access20.500.12749/9990oai:repository.unab.edu.co:20.500.12749/99902024-04-29 22:00:59.892open accessRepositorio Institucional | Universidad Autónoma de Bucaramanga - UNABrepositorio@unab.edu.co

Publicaciones similares